Counselors in Flandreau, SD Accepting Medicare

3 Counselors found. Showing 1 - 3

Mrs. Alla Anatoly Jones, LPC-MH, LAC, QMHP Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 805 W Pipestone Ave, Flandreau, SD 57028 Phone: 605-573-2000    Fax: 605-573-2002

Mrs. Lacey M Albers I, M.S., LPC, NCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3101 S. Veterans Street, Flandreau, SD 57028 Phone: 605-997-3844    Fax: 605-997-3694

Cynthia Marie Johanson, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 48251 229th St, Flandreau, SD 57028 Phone: 605-864-0891

News Archive

Adjuvant chemotherapy can improve overall survival in patients with high-risk, low-grade glioma

A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.

Broadly neutralizing antibody delays return of viral rebound in HIV-1 infected individuals

The administration of VRC01, a potent and broadly neutralizing HIV-specific antibody, is safe, is well-tolerated, generated high plasma concentrations and modestly delayed the return of HIV viral rebound in HIV-1 infected individuals after they stopped receiving antiretroviral therapy, according to a study published in the New England Journal of Medicine by researchers at the University of Alabama at Birmingham, the National Institutes of Health and the University of Pennsylvania Penn Center for AIDS Research.

Democrats fight back against lawsuit threatening health law

Democrats on Thursday officially launched their pushback against a December federal court decision that declared the Affordable Care Act unconstitutional.

LabCorp announces nationwide availability of Risk of Ovarian Malignancy Algorithm

Laboratory Corporation of America Holdings announced today the nationwide availability of a new FDA cleared risk stratification tool (ROMA, Risk of Ovarian Malignancy Algorithm) that combines the results for Fujirebio HE4, Abbott's ARCHITECT CA 125 II, and menopausal status into a numerical score that, along with clinical and radiological evaluation, can aid in evaluating whether a woman over the age of 18 who presents with an ovarian mass and for whom surgery is planned is at high or low likelihood of finding malignancy on surgery.

Read more Medical News

› Verified 1 days ago